請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62148
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 盧國賢(Kuo-Shyan Lu) | |
dc.contributor.author | Cheng-Kai Huang | en |
dc.contributor.author | 黃政凱 | zh_TW |
dc.date.accessioned | 2021-06-16T13:30:25Z | - |
dc.date.available | 2018-09-24 | |
dc.date.copyright | 2013-09-24 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-07-22 | |
dc.identifier.citation | Ahuja, P., P. Sdek, et al. (2007). 'Cardiac myocyte cell cycle control in development, disease, and regeneration.' Physiol Rev 87(2): 521-544.
Banerjee, I., J. W. Fuseler, et al. (2007). 'Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse.' Am J Physiol Heart Circ Physiol 293(3): 1883-1891. Bax, N. A., M. H. van Marion, et al. (2012). 'Matrix production and remodeling capacity of cardiomyocyte progenitor cells during in vitro differentiation.' J Mol Cell Cardiol 53(4): 497-508. Bergmann, O., R. D. Bhardwaj, et al. (2009). 'Evidence for cardiomyocyte renewal in humans.' Science 324(5923): 98-102. Chaudhry, H. W., N. H. Dashoush, et al. (2004). 'Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium.' J Biol Chem 279(34): 35858-35866. Ciemerych, M. A., K. Archacka, et al. (2011). 'Cell cycle regulation during proliferation and differentiation of mammalian muscle precursor cells.' Results Probl Cell Differ 53: 473-527. Clause, K. C., J. Tchao, et al. (2012). 'Developing cardiac and skeletal muscle share fast-skeletal myosin heavy chain and cardiac troponin-I expression.' PLoS One 7(7): e40725. Cokkinos, D. V. and C. Pantos (2011). 'Myocardial remodeling, an overview.' Heart Fail Rev 16(1): 1-4. den Elzen, N. and J. Pines (2001). 'Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase.' J Cell Biol 153(1): 121-136. Deutsch, M. A., A. Sturzu, et al. (2013). 'At a crossroad: cell therapy for cardiac repair.' Circ Res 112(6): 884-890. di Giacomo, V., M. Rapino, et al. (2010). 'PKC-delta signalling pathway is involved in H9c2 cells differentiation.' Differentiation 80(4-5): 204-212. Geley, S., E. Kramer, et al. (2001). 'Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint.' J Cell Biol 153(1): 137-148. Greulich, F., C. Rudat, et al. (2011). 'Mechanisms of T-box gene function in the developing heart.' Cardiovasc Res 91(2): 212-222. Halevy, O., B. G. Novitch, et al. (1995). 'Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.' Science 267(5200): 1018-1021. Hescheler, J., R. Meyer, et al. (1991). 'Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart.' Circulation Research 69(6): 1476-1486. Hoover-Plow, J. and Y. Gong (2012). 'Challenges for heart disease stem cell therapy.' Vasc Health Risk Manag 8: 99-113. Hotchkiss, A., J. Robinson, et al. (2012). 'Role of D-type cyclins in heart development and disease.' Can J Physiol Pharmacol 90(9): 1197-1207. Ieda, M. (2013). 'Heart regeneration using reprogramming technology.' Proceedings of the Japan Academy, Series B 89(3): 118-128. Ikenishi, A., H. Okayama, et al. (2012). 'Cell cycle regulation in mouse heart during embryonic and postnatal stages.' Dev Growth Differ 54(8): 731-738. Jacobs, H. W., E. Keidel, et al. (2001). 'A complex degradation signal in Cyclin A required for G1 arrest, and a C-terminal region for mitosis.' EMBO J 20(10): 2376-2386. Kamrul Hasan, M., Y. Komoike, et al. (2010). 'Myogenic differentiation in atrium-derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoter.' Genes Cells 15(5): 439-454. Kimes, B. W. and B. L. Brandt (1976). 'Properties of a clonal muscle cell line from rat heart.' Exp Cell Res 98(2): 367-381. Lassar, A. B., S. X. Skapek, et al. (1994). 'Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal.' Curr Opin Cell Biol 6(6): 788-794. Lundy, S. D., W. Z. Zhu, et al. (2013). 'Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells.' Stem Cells Dev. (Epub ahead of print) Mastroyiannopoulos, N. P., P. Nicolaou, et al. (2012). 'Down-regulation of myogenin can reverse terminal muscle cell differentiation.' PLoS One 7(1): e29896. Olson, E. N. (1993). 'Regulation of muscle transcription by the MyoD family. The heart of the matter.' Circulation Research 72(1): 1-6. Pagano, M., S. Naviglio, et al. (2004). 'Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system.' J Cell Physiol 198(3): 408-416. Pikkarainen, S., H. Tokola, et al. (2004). 'GATA transcription factors in the developing and adult heart.' Cardiovasc Res 63(2): 196-207. Pual Riley, L. A.-C. J. C. C. (1998). 'The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis.' Nature Genetics 18: 271-275. Risebro, C. A., N. Smart, et al. (2006). 'Hand1 regulates cardiomyocyte proliferation versus differentiation in the developing heart.' Development 133(22): 4595-4606. Sabourin, L. A. and M. A. Rudnicki (2000). 'The molecular regulation of myogenesis.' Clin Genet 57(1): 16-25. Segers, V. F. and R. T. Lee (2008). 'Stem-cell therapy for cardiac disease.' Nature 451(7181): 937-942. Soonpaa, M. H. and L. J. Field (1997). 'Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts.' Am J Physiol 272(1 Pt 2): H220-226. Sweeney, C., M. Murphy, et al. (1996). 'A distinct cyclin A is expressed in germ cells in the mouse.' Development 122(1): 53-64. Sylva, M., M. J. van den Hoff, et al. (2013). 'Development of the Human Heart.' Am J Med Genet A (Epub ahead of print) Taylor, D. O., L. B. Edwards, et al. (2008). 'Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report--2008.' J Heart Lung Transplant 27(9): 943-956. Walsh, K. and H. Perlman (1997). 'Cell cycle exit upon myogenic differentiation.' Curr Opin Genet Dev 7(5): 597-602. Wang, W., M. C. Caldwell, et al. (2000). 'HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.' EMBO J 19(10): 2340-2350. Woo, Y. J., C. M. Panlilio, et al. (2006). 'Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure.' Circulation 114(1 Suppl): I206-213. Woo, Y. J., C. M. Panlilio, et al. (2007). 'Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.' J Thorac Cardiovasc Surg 133(4): 927-933. Yaqin Tu, C. C., Junru Pan, et al. (2012). 'The Ubiquitin Proteasome Pathway (UPP) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis.' Int J Clin Exp Pathol 5(8): 726-738. Yusuf, F. and B. Brand-Saberi (2012). 'Myogenesis and muscle regeneration.' Histochem Cell Biol 138(2): 187-199. Zara, S., M. Falconi, et al. (2011). 'pPKCdelta activates SC35 splicing factor during H9c2 myoblastic differentiation.' Histol Histopathol 26(1): 59-69. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62148 | - |
dc.description.abstract | 心肌細胞一直被認為是分化完全且不再進行分裂的細胞,但近來有研究指出:成熟心肌細胞仍然具有增殖的能力,只是由於細胞週期調控蛋白如cyclin A2表現大幅減少,導致具有增殖活性的心肌細胞比例極小。在C2C12骨骼肌細胞實驗中已被證實透過肌細胞生成素(myogenin)表達使得肌肉細胞分化時會抑制其增殖活性,但分化路徑是否同樣影響心肌細胞分裂活性則尚未明瞭,因此,本研究主要探討myogenin與cyclin A2兩者間之關聯性對於心肌細胞分化與增殖的調控機轉。
本研究之動物實驗結果顯示:在大鼠胚胎心肌細胞內大量表現的週期素cyclin A2,在出生後大幅降低;相反的,在同一時期的肌細胞生成素myogenin,表現量則是由極少量而大幅升高。再以大鼠心肌母細胞株H9c2作為研究材料,並以1 %馬血清(horse serum)培養H9c2細胞以誘導其分化,來模擬分化完全的心肌細胞,研究結果顯示:以1 %馬血清誘導分化後的H9c2細胞,其生長停止並產生肌肉組織之分化特徵”肌管(myotube)”,進一步發現,隨著細胞的分化,cyclin A2含量降低而myogenin含量上升,與動物實驗之結果相符。前人研究指出Ubiquitin-Proteasome System (UPS)可能在蛋白質的調控機轉上扮演重要角色,本論文之實驗結果也顯示:1 %馬血清誘導分化後的H9c2細胞株,經蛋白酶體抑制劑(proteasome inhibitor, MG132)作用後,可使cyclin A2上升,同時使myogenin下降。此外,以藥物MG132處理後,處於細胞週期G2-M phase中的細胞比例增加,顯示細胞分裂正在進行中;若以siRNA抑制myogenin表現後,亦可發現cyclin A2上升。綜合以上實驗結果顯示,大鼠出生後心肌細胞增殖能力大幅下降可能是由於心肌細胞走向分化路徑進而抑制細胞分裂所造成,而此現象可以被調控且逆轉。我們期待未來在臨床上能透過抑制心肌分化誘使心肌增殖能力提高, 進而應用於修復心肌受損。 | zh_TW |
dc.description.abstract | Cardiomyocytes are traditionally regarded as terminal differentiated cells and being permanently withdrawn from the cell cycle. Recent studies showed that mature cardiomyocytes still have the ability to proliferate; however, the regulators of cell cycle, such as cyclin A2 expression are little to detect, so the proportion of cardiomyocytes with proliferative activity is very low. In skeletal muscle cell line, C2C12 cells, the proliferative activity was inhibited through myogenin expression during muscle differentiation; however, the effect of differentiation on cardiomyocyte proliferation remains unknown. Therefore, the purpose of this study is to explore the correlation of cyclin A2 and myogenin on the proliferation and differentiation of
cardiomyocytes. In vivo studies revealed that cyclin A2 was strongly expressed in rat embryonic heart and decreased immediately after birth. In contrast, expression level of myogenin changed from trace to great amount. Moreover, the in vitro studies on rat cardiomyoblast, H9c2 cell line, demonstrated that the expression levels of cyclin A2 decreased and myogenin increased after replacing the medium with 1 % horse serum to induce the differentiation of cardiomyocytes. Previous studies indicated that ubiquitin-proteasome system (UPS) might play an important role in the regulation of expression level of proliferation and differentiation regulatory proteins, including cyclin A2 and myogenin. Our results indicated that the treatment of MG132, a reversible and cell-permeable proteasome inhibitor, resulted in an increase of cyclin A2 and a decrease of myogenin protein levels. Similar results were observed with siRNA inhibition targeting to myogenin expression. We also found that the proportion of cardiomyocytes at G2-M phase increased when treated with MG132, suggesting the cell cycle is in progression. Taking all results together, we concluded that (1) differentiation pathway dominates the growth in cardiomyocytes after birth so that cardiomyocytes have low proliferative activity, and (2) this phenomenon is reversible and can be regulated. We expect the results of present study may apply for cardiac injury repair through enhancing the cardiomyocytes proliferative activity in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T13:30:25Z (GMT). No. of bitstreams: 1 ntu-102-R00446009-1.pdf: 9782916 bytes, checksum: 9d9e688f6367d4eb6ff774f55f0e77f5 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 口試委員會審定書 #
誌謝 i 摘要 ii ABSTRACT iii CONTENTS iv Chapter 1 Introduction 1 1.1 Myogenesis 1 1.1.1 Striated muscle myogenesis 1 1.1.2 Cardiomyogenesis 3 1.2 Cell Cycle 4 1.2.1 Cell cycle and regulators 4 1.2.2 The role of cyclin A2 in cell cycle 5 1.2.3 Cell cycle of cardiomyocyte 6 1.3 The Relationship between Muscle Cell Differentiation and Cell Cycle Progression 7 1.4 Ubiquitin-Proteasome System (UPS) 8 Chapter 2 Aims 10 Chapter 3 Materials and Methods 11 3.1 Animal Experiment 11 3.2 Cell Culture, Chemical Treatment and Differentiation Induction 11 3.3 Immunocytochemistry 12 3.4 Western Blot 14 3.5 Reverse Transcriptase-Polymerase Chain Reaction 14 3.6 Cell Cycle Analysis 15 3.7 TUNEL Assay 16 3.8 siRNA Transfection 16 3.9 Cell Proliferation Assay 17 Chapter 4 Results 19 4.1 Cardiomyocytes undergo differentiation pathway rather than proliferation pathway during rat heart development. 19 4.2 H9c2 cells are induced to differentiated under low serum condition following with down-regulation of cyclin A2 and up-regulation of myogenin. 21 4.3 Inhibition of proteasome activity by MG132 up-regulates cyclin A2 and promotes cell cycle progression of H9c2 cells 22 4.4 Cyclin A2 is crucial for proliferation and myogenin is not the major transcription factor for differentiation of cardiomyocytes. 24 Chapter 5 Discussion 26 5.1 Cardiomyocytes undergo proliferative pathway in embryonic stage and switch to differentiation pathway in neonatal and adult stage. 26 5.2 Cyclin A2 is important for heart development. 28 5.3 Myogenin can be a cardiomyogenesis marker. 29 5.4 Differentiated state of cardiomyocytes can be partially inhibited through downregulation of myogenin. 30 5.5 Clinical application 31 References 33 Table and Figures 40 | |
dc.language.iso | en | |
dc.title | Myogenin與Cyclin A2可調控心肌細胞之分化與增殖 | zh_TW |
dc.title | Myogenin and Cyclin A2 Regulate Differentiation and Proliferation of Cardiomyocytes | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 周逸鵬,龔秀妮,張綺芬,周?珠 | |
dc.subject.keyword | 心肌細胞,分化,週期素A2,肌細胞生成素,蛋白?體, | zh_TW |
dc.subject.keyword | cardiomyocyte,differentiation,cyclin A2,myogenin,proteasome, | en |
dc.relation.page | 75 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-07-22 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 解剖學暨細胞生物學研究所 | zh_TW |
顯示於系所單位: | 解剖學暨細胞生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 9.55 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。